cas 1119454-05-5|| where to buy 3,5-Dichloro-2-ethynylpyridine

Nom du produit:3,5-Dichloro-2-ethynylpyridine

IUPAC Name:3,5-dichloro-2-ethynylpyridine

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1119454-05-5 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1119454-05-5; Formule moléculaire:C7H3Cl2N; Point de fusion:-; Code SMILES:C#CC1=NC=C(Cl)C=C1Cl; Densité:

: Numéro de catalogue:CM1075503; Poids moléculaire:172.01; Point d'ébullition:; N° Mdl:; Stockage:

: Pyridines; Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.; Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu; Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer; Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

: Vadadustat; March 27, 2024, Akebia received FDA approval of Vafseo(vadadustat) tablets for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.
Vafseo(vadadustat) tablets is a once-daily oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor that activates the physiologic response to hypoxia to stimulate endogenous production of erythropoietin, increasing hemoglobin and red blood cell production to manage anemia.